Literature DB >> 20360591

Brain injury caused by chronic fetal hypoxemia is mediated by inflammatory cascade activation.

Rong Guo1, Weijian Hou, Yafeng Dong, Zhiyong Yu, Josh Stites, Carl P Weiner.   

Abstract

The prevalence of cerebral palsy (CP) shows little temporal or geographic variation and is associated with preterm birth, maternal/fetal infection/inflammation, and fetal growth restriction (IUGR), a potential surrogate for chronic fetal hypoxemia (CHX). We previously demonstrated CHX causes a fetal inflammatory response syndrome (FIRS). Herein, we test the hypothesis that CHX may cause fetal brain injury by upregulating inflammatory cytokine cascades, culminating in apoptosis pathway activation. Time-mated guinea pigs were housed in 12% or 10.5% O(2) for the last 21% of gestation. Chronic fetal hypoxemia increased the lactate/pyruvate and decreased the glutathione (GSH)/oxidized glutathione (GSSH) ratios, confirming a shift to a prooxidant state. The end result was a >30% decrease in hippocampal neuron density. Based on a microarray spotted with 113 cytokines and receptors, 22 genes were upregulated by CHX in proportion to the degree of hypoxia; the findings were confirmed by quantitative polymerase chain reaction (PCR). Thus, CHX triggers fetal brain inflammation inversely proportional to its severity characterized by increased apoptosis and neuronal loss. We suggest CHX fetal brain injury is not directly caused by oxygen deprivation but rather is an adaptive response that becomes maladaptive.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360591     DOI: 10.1177/1933719110364061

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  33 in total

1.  Chronic fetal hypoxia produces selective brain injury associated with altered nitric oxide synthases.

Authors:  Yafeng Dong; Zhiyong Yu; Yan Sun; Hui Zhou; Josh Stites; Katherine Newell; Carl P Weiner
Journal:  Am J Obstet Gynecol       Date:  2011-01-26       Impact factor: 8.661

Review 2.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

Review 3.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 4.  Therapeutic potential to reduce brain injury in growth restricted newborns.

Authors:  Julie A Wixey; Kirat K Chand; Lily Pham; Paul B Colditz; S Tracey Bjorkman
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

Review 5.  ASAS-SSR Triennnial Reproduction Symposium: Looking Back and Moving Forward-How Reproductive Physiology has Evolved: Fetal origins of impaired muscle growth and metabolic dysfunction: Lessons from the heat-stressed pregnant ewe.

Authors:  Dustin T Yates; Jessica L Petersen; Ty B Schmidt; Caitlin N Cadaret; Taylor L Barnes; Robert J Posont; Kristin A Beede
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

6.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

7.  Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.

Authors:  Clifford W Mason; Gene T Lee; Yafeng Dong; Helen Zhou; Lily He; Carl P Weiner
Journal:  Drug Metab Dispos       Date:  2014-09-26       Impact factor: 3.922

Review 8.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

9.  Growth hormone deficiency and cerebral palsy.

Authors:  Jesús Devesa; Nerea Casteleiro; Cristina Rodicio; Natalia López; Pedro Reimunde
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

10.  Potential role of Toll-like receptors in programming of vascular dysfunction.

Authors:  Jennifer A Thompson; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2013-03-13       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.